Status:

COMPLETED

Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin

Lead Sponsor:

Asan Medical Center

Conditions:

Advanced Gastric Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is: * To observe the feasibility of biweekly oxaliplatin and infusional 5-fluorouracil (FU)/Leucovorin (LV) in patients with advanced gastric adenocarcinoma who have prior e...

Detailed Description

There is presently no chemotherapy regimen considered to be the standard of care for patients with advanced gastric cancer. However, more and more patients will receive fluoropyrimidine, platinum, and...

Eligibility Criteria

Inclusion

  • Pathologically proven non-resectable adenocarcinoma of stomach
  • Measurable disease based on Response Criteria in Solid Tumors (RECIST)
  • Prior chemotherapy with taxane, fluoropyrimidine, and cisplatinum in combination or sequentially, there is no time limit for the last chemotherapy
  • Age 18 to 70 years old
  • Estimated life expectancy of more than 3 months
  • Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower
  • Adequate bone marrow function (white blood cell counts \>4,000/µL, absolute neutrophil count \[ANC\]\>1,500/µL, hemoglobin \>9.0 g/dL, and platelets\>100,000/µL),
  • Adequate kidney function (creatinine\<1.5 mg/dL)
  • Adequate liver function (bilirubin\<1.5 mg/dL , transaminases levels\<3 times the upper normal limit \[5 times for patients with liver metastasis\], and serum albumin of \>2.5 mg/dL)

Exclusion

  • Other tumor type than adenocarcinoma
  • Presence or history of central nervous system metastasis
  • Obvious or impending bowel obstruction (including obvious peritoneal carcinomatosis)
  • Evidence of active gastrointestinal bleeding
  • Other serious illness or medical conditions

Key Trial Info

Start Date :

October 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT00976768

Start Date

October 1 2004

End Date

December 1 2009

Last Update

January 7 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Asan medical center

Seoul, South Korea, 138-736